Gallery
- Karnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)Wedding pics: Mouni Roy marries Suraj Nambiar in South Indian ceremony73rd Republic Day Parade 2022 - In Pictures
First Serve, an NGO founded by Reyaan Punj, recently organised the second edition of AITA
- Bajrang Punia provisionally suspended by NADA, Paris berth at stake: Sources
- Laureus Award 2024 : Novak Djokovic, Aitana Bonmati win top honours at Laureus Sports Awards
- Asian Games medallist Jyothi Yarraji to train in Spain ahead of Paris Olympics
- Lione Messi said Retirement not on my mind
- Indian Wells: Alcaraz, Swiatek win titles
Centre approves Russia’s COVID-19 vaccine Sputnik V Last Updated : 12 Apr 2021 06:07:45 PM IST A government expert panel has given its nod to emergency use authorisation of Russian-made Covid vaccine, Sputnik-V, in India, Union Health Ministry sources said.
After the Drug Controller General of India gives assent to the Subject Expert Committee's approval, the sources told IANS, India will have a third Covid vaccine after AstraZeneca-Oxford University developed-Serum Institute of India-manufactured Covishield and Bharat Biotech-developed and manufactured Covaxin.Indian Council of Medical Research's (ICMR) Dr N.K. Arora, talking to IANS, said: "Though, I am yet to receive any official information about its approval, but it would be good news for India if it is approved."Explaining features of this vaccine, Arora said: "Sputnik is a two dose vaccine. The composition of the first dose will be different from the second dose and there should be at least a three to four weeks gap between the first dose and the second. The published data suggest that it has 91 per cent efficacy. Some more clarity on it will also come soon."The development has come at a time when India is witnessing an exponential surge in Covid-19 cases and vaccines have been much in demand.IANS New Delhi For Latest Updates Please-
Join us on
Follow us on
172.31.16.186